Today: 1 February 2026
Subscribe
Browse Category

NYSE:VZ News 21 December 2025 - 27 December 2025

Verizon Stock (VZ) Holds Near $40 as Dividend Calendar, Analyst Targets and Frontier Deal Stay in Focus Heading Into Monday

Verizon Stock (VZ) Holds Near $40 as Dividend Calendar, Analyst Targets and Frontier Deal Stay in Focus Heading Into Monday

NEW YORK, Dec. 27, 2025, 3:34 p.m. ET — Market closed (Weekend). Verizon Communications Inc. (NYSE: VZ) heads into the final week of the year with its stock parked around the low-$40s after a quiet, post-Christmas trading day on Wall Street. Verizon last closed at $40.48, up about 0.4% from the prior session, after trading between $40.24 and $40.53. The…
27 December 2025
·····
Verizon (VZ) Stock News Today: Dividend, Frontier Deal Updates, Analyst Forecasts — and What to Watch Before Monday’s Open

Verizon (VZ) Stock News Today: Dividend, Frontier Deal Updates, Analyst Forecasts — and What to Watch Before Monday’s Open

New York time check: As of 1:30 a.m. ET on Saturday, December 27, 2025, U.S. markets are closed. That timing matters because Verizon Communications Inc. (NYSE: VZ) is heading into the final full trading sessions of 2025 with several headline-moving narratives in play: year-end market positioning, a major fiber acquisition that’s still clearing state approvals, a large restructuring plan, and…
27 December 2025
····
Verizon (VZ) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Verizon (VZ) Stock: What to Know Before the Market Opens on Dec. 26, 2025

U.S. stocks reopen Friday, Dec. 26, 2025 after the Christmas Day closure, with Verizon Communications Inc. (NYSE: VZ) coming into the session with a familiar setup: a high dividend, a low valuation, and multiple company-specific catalysts that can move the narrative quickly in thin post-holiday trading. Barron’s Verizon shares last traded in the holiday-shortened session on Wednesday, Dec. 24, closing…
26 December 2025
····
Verizon Stock (VZ) After Hours Today: Christmas Eve Close, Fresh Analysis, and What to Watch Before Markets Reopen

Verizon Stock (VZ) After Hours Today: Christmas Eve Close, Fresh Analysis, and What to Watch Before Markets Reopen

Verizon Communications Inc. (NYSE: VZ) finished the holiday-shortened Christmas Eve session (Wednesday, Dec. 24, 2025) higher, then eased slightly in after-hours trading as liquidity thinned into the holiday break. With U.S. stock markets closed on Christmas Day (Thursday, Dec. 25), the more practical “next open” for Verizon shares is Friday, Dec. 26, 2025—and investors will be weighing a mix of…
25 December 2025
····
Verizon (VZ) Stock After Hours: What Happened After the Dec. 23, 2025 Close—and What to Watch Before the Dec. 24 Early-Close Session

Verizon (VZ) Stock After Hours: What Happened After the Dec. 23, 2025 Close—and What to Watch Before the Dec. 24 Early-Close Session

Verizon Communications Inc. (NYSE: VZ) ended Tuesday, December 23, 2025, with a muted move—both during the regular session and after the bell—even as the broader market pushed higher into the holiday stretch. In late trading, VZ was quoted at about $39.95 (+0.08%) after hours versus a regular-session close near $39.92 (-0.15%), reflecting a day where investors largely stayed in “digest…
24 December 2025
····
Verizon Stock (VZ) News Today: Frontier Deal Approvals, 5G Tower Partnership, Dividend Outlook and 2026 Catalysts (Dec. 21, 2025)

Verizon Stock (VZ) News Today: Frontier Deal Approvals, 5G Tower Partnership, Dividend Outlook and 2026 Catalysts (Dec. 21, 2025)

Verizon Communications Inc. (NYSE: VZ) heads into the final full trading week of 2025 with investors focused on two big themes: the march toward closing its Frontier Communications acquisition and the company’s push to keep network investment efficient while protecting cash flow. With U.S. markets closed on Sunday, December 21, 2025, the most recent trading print reflects Friday’s session, when…
21 December 2025
····
1 2 3 4

Stock Market Today

  • Sarepta Therapeutics' 82% Stock Plunge Suggests 73% Undervaluation According to DCF Analysis
    February 1, 2026, 2:57 AM EST. Sarepta Therapeutics (SRPT) has seen an 82.1% share price decline over the past year, fueling debate on its true market value. Despite recent setbacks tied to regulatory and pipeline updates, a discounted cash flow (DCF) model estimates the stock's intrinsic value at $75.97 per share, implying it is 73.2% undervalued relative to current prices. The DCF approach projects positive free cash flow growth from a loss of $360 million to $466 million by 2030. Additionally, Sarepta's price-to-sales ratio of 0.88x remains below the biotech sector average, indicating potential undervaluation. Investors are re-evaluating risk and growth prospects amid shifting biotech sector sentiment and Sarepta's volatile earnings profile.
Go toTop